Influencing factors of early dramatic recovery of neurological function after intravenous thrombolysis in patients with branch atheromatous disease

被引:4
作者
Meng, Yuanyuan [1 ]
Zhao, Yanjun [2 ]
Wang, Ruixia [3 ]
Wen, Jiangshan [4 ]
Tang, Tianping [1 ]
机构
[1] Shengli Oilfield Cent Hosp, Dept Neurol, 31 Jinan Rd, Dongying 257034, Peoples R China
[2] Weifang Peoples Hosp, Dept Rehabil, Weifang, Peoples R China
[3] Tianjin Med Univ, Hosp 2, Dept Neurol, Tianjin, Peoples R China
[4] Zibo Cent Hosp, Dept Crit Care Med, Zibo, Peoples R China
基金
英国科研创新办公室;
关键词
branch atheromatous disease; early dramatic recovery; parapontine median artery; thrombolysis; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; RECANALIZATION; IMPROVEMENT; DETERIORATION; PREDICTORS; MECHANISMS; ALTEPLASE; THERAPY;
D O I
10.1097/MD.0000000000033658
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Intravenous thrombolysis can significantly improve the neurological function of patients with acute ischemic stroke. However, the expected early dramatic recovery (EDR) of neurological function after thrombolysis is not achieved in some patients with branch atheromatous disease (BAD). Here we evaluated the factors associated with EDR after thrombolysis in BAD patients. Methods:We conducted a retrospective study on 580 consecutive BAD patients. All patients met the diagnostic criteria of BAD and received intravenous recombinant tissue-type plasminogen activator (rt-PA). EDR was defined when the improvement of National Institutes of Health Stroke Scale (NIHSS) score was >8 points within 2 or 24 hours after rt-PA, or the total NIHSS score was 0 or 1. The factors associated with EDR were analyzed with multivariate logistic regression analysis. Results:Among 580 patients, the incidence of EDR was 35.2% (204 cases). Compared with patients without EDR, patients with EDR had lower incidence of diabetes (15.7% vs 29.3%, P < .001), lower NIHSS scores at 2 and 24 hours after rt-PA (P < .001), less cerebral hemorrhage (0% vs 5.3%, P = .001), and shorter onset to treatment time (OTT) (P < .001). Multivariate logistic regression analysis in propensity score-matched cohort showed that EDR was associated with OTT (adjusted OR = 0.994; 95% CI, 0.989-0.999) and NIHSS score after rt-PA (adjusted OR = 0.768; 95% CI, 0.663-0.890). Notably, diabetes (adjusted OR = 0.477, 95% CI, 0.234-0.972) was an independent factor related to EDR of neurological function in BAD patients. In the subgroup analysis, a lower incidence of diabetes (adjusted OR = 0.205, 95% CI: 0.059-0.714, P = .013) and a lower NIHSS score after thrombolysis in patients with paramedian pontine infarction (adjusted OR = 0.809, 95% CI: 0.656-0.997, P = .047) were significantly associated with EDR. Conclusion:Diabetes is not conducive to EDR of neurological function in patients with BAD, especially in patients with paramedian pontine infraction. Low NIHSS score and short OTT after thrombolysis may be closely related to EDR after intravenous thrombolysis.
引用
收藏
页数:7
相关论文
共 32 条
  • [1] Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo
    Agarwal, Shashank
    Scher, Erica
    Lord, Aaron
    Frontera, Jennifer
    Ishida, Koto
    Torres, Jose
    Rostanski, Sara
    Mistry, Eva
    Mac Grory, Brian
    Cutting, Shawna
    Burton, Tina
    Silver, Brian
    Liberman, Ava L.
    Lerario, Mackenzie P.
    Furie, Karen
    Grotta, James
    Khatri, Pooja
    Saver, Jeffrey
    Yaghi, Shadi
    [J]. STROKE, 2020, 51 (04) : 1226 - 1230
  • [2] The Effect of Clot Volume and Permeability on Response to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke
    Bilgic, Adnan Burak
    Gocmen, Rahsan
    Arsava, Ethem Murat
    Topcuoglu, Mehmet Akif
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (02)
  • [3] Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: A hospital-based study from south India
    Boddu, Demudu Babu
    Bandaru, V. C. S. Srinivasarao
    Reddy, Prasad G.
    Madhusudan, M.
    Rukmini, M. K.
    Suryaprabha, T.
    Jabeen, S. A.
    Suvarna, A.
    Jayalakshmi, Sita S.
    Meena, A. K.
    Borgohain, Rupam
    Kaul, Subhash
    [J]. NEUROLOGY INDIA, 2010, 58 (03) : 403 - 406
  • [4] Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
    Campbell, B. C. V.
    Mitchell, P. J.
    Kleinig, T. J.
    Dewey, H. M.
    Churilov, L.
    Yassi, N.
    Yan, B.
    Dowling, R. J.
    Parsons, M. W.
    Oxley, T. J.
    Wu, T. Y.
    Brooks, M.
    Simpson, M. A.
    Miteff, F.
    Levi, C. R.
    Krause, M.
    Harrington, T. J.
    Faulder, K. C.
    Steinfort, B. S.
    Priglinger, M.
    Ang, T.
    Scroop, R.
    Barber, P. A.
    McGuinness, B.
    Wijeratne, T.
    Phan, T. G.
    Chong, W.
    Chandra, R. V.
    Bladin, C. F.
    Badve, M.
    Rice, H.
    de Villiers, L.
    Ma, H.
    Desmond, P. M.
    Donnan, G. A.
    Davis, S. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (11) : 1009 - 1018
  • [5] Tissue plasminogen activator for acute ischemic stroke in clinical practice - A meta-analysis of safety data
    Graham, GD
    [J]. STROKE, 2003, 34 (12) : 2847 - 2850
  • [6] Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
    Hacke, Werner
    Kaste, Markku
    Bluhmki, Erich
    Brozman, Miroslav
    Davalos, Antoni
    Guidetti, Donata
    Larrue, Vincent
    Lees, Kennedy R.
    Medeghri, Zakaria
    Machnig, Thomas
    Schneider, Dietmar
    von Kummer, Ruediger
    Wahlgren, Nils
    Toni, Danilo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) : 1317 - 1329
  • [7] Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
    Hart, R. G.
    Sharma, M.
    Mundl, H.
    Kasner, S. E.
    Bangdiwala, S. I.
    Berkowitz, S. D.
    Swaminathan, B.
    Lavados, P.
    Wang, Y.
    Wang, Y.
    Davalos, A.
    Shamalov, N.
    Mikulik, R.
    Cunha, L.
    Lindgren, A.
    Arauz, A.
    Lang, W.
    Czlonkowska, A.
    Eckstein, J.
    Gagliardi, R. J.
    Amarenco, P.
    Ameriso, S. F.
    Tatlisumak, T.
    Veltkamp, R.
    Hankey, G. J.
    Toni, D.
    Bereczki, D.
    Uchiyama, S.
    Ntaios, G.
    Yoon, B. -W.
    Brouns, R.
    Endres, M.
    Muir, K. W.
    Bornstein, N.
    Ozturk, S.
    O'Donnell, M. J.
    Basson, M. M. De Vries
    Pare, G.
    Pater, C.
    Kirsch, B.
    Sheridan, P.
    Peters, G.
    Weitz, J. I.
    Peacock, W. F.
    Shoamanesh, A.
    Benavente, O. R.
    Joyner, C.
    Themeles, E.
    Connolly, S. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (23) : 2191 - 2201
  • [8] Neuroimaging Markers for Early Neurologic Deterioration in Single Small Subcortical Infarction
    Jeong, Han-Gil
    Kim, Beom Joon
    Yang, Mi Hwa
    Han, Moon-Ku
    Bae, Hee-Joon
    [J]. STROKE, 2015, 46 (03) : 687 - 691
  • [9] Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
    Jovin, T. G.
    Chamorro, A.
    Cobo, E.
    de Miquel, M. A.
    Molina, C. A.
    Rovira, A.
    San Roman, L.
    Serena, J.
    Abilleira, S.
    Ribo, M.
    Millan, M.
    Urra, X.
    Cardona, P.
    Lopez-Cancio, E.
    Tomasello, A.
    Castano, C.
    Blasco, J.
    Aja, L.
    Dorado, L.
    Quesada, H.
    Rubiera, M.
    Hernandez-Perez, M.
    Goyal, M.
    Demchuk, A. M.
    von Kummer, R.
    Gallofre, M.
    Davalos, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (24) : 2296 - 2306
  • [10] Factors associated with early dramatic recovery following successful recanalization of occluded artery by endovascular treatment in anterior circulation stroke
    Kim, Dae-Hyun
    Nah, Hyun-Wook
    Park, Hyun-Seok
    Choi, Jae-Hyung
    Kang, Myung-Jin
    Cha, Jae-Kwan
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2017, 46 : 171 - 175